Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 2
1990 5
1992 2
1994 1
1995 5
1996 3
1997 8
1998 6
1999 8
2000 7
2001 6
2002 14
2003 16
2004 10
2005 14
2006 10
2007 9
2008 18
2009 19
2010 18
2011 21
2012 19
2013 21
2014 30
2015 24
2016 22
2017 27
2018 14
2019 18
2020 13
2021 27
2022 23
Text availability
Article attribute
Article type
Publication date

Search Results

401 results
Results by year
Filters applied: . Clear all
Page 1
AKT/PKB Signaling: Navigating the Network.
Manning BD, Toker A. Manning BD, et al. Among authors: toker a. Cell. 2017 Apr 20;169(3):381-405. doi: 10.1016/j.cell.2017.04.001. Cell. 2017. PMID: 28431241 Free PMC article. Review.
PI3K signaling in cancer: beyond AKT.
Lien EC, Dibble CC, Toker A. Lien EC, et al. Among authors: toker a. Curr Opin Cell Biol. 2017 Apr;45:62-71. doi: 10.1016/j.ceb.2017.02.007. Epub 2017 Mar 24. Curr Opin Cell Biol. 2017. PMID: 28343126 Free PMC article. Review.
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.
Li Y, Qiu X, Wang X, Liu H, Geck RC, Tewari AK, Xiao T, Font-Tello A, Lim K, Jones KL, Morrow M, Vadhi R, Kao PL, Jaber A, Yerrum S, Xie Y, Chow KH, Cejas P, Nguyen QD, Long HW, Liu XS, Toker A, Brown M. Li Y, et al. Among authors: toker a. Nat Cell Biol. 2021 Nov;23(11):1187-1198. doi: 10.1038/s41556-021-00781-z. Epub 2021 Nov 4. Nat Cell Biol. 2021. PMID: 34737445
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors.
Muik A, Garralda E, Altintas I, Gieseke F, Geva R, Ben-Ami E, Maurice-Dror C, Calvo E, LoRusso PM, Alonso G, Rodriguez-Ruiz ME, Schoedel KB, Blum JM, Sänger B, Salcedo TW, Burm SM, Stanganello E, Verzijl D, Vascotto F, Sette A, Quinkhardt J, Plantinga TS, Toker A, van den Brink EN, Fereshteh M, Diken M, Satijn D, Kreiter S, Breij ECW, Bajaj G, Lagkadinou E, Sasser K, Türeci Ö, Forssmann U, Ahmadi T, Şahin U, Jure-Kunkel M, Melero I. Muik A, et al. Among authors: toker a. Cancer Discov. 2022 May 2;12(5):1248-1265. doi: 10.1158/2159-8290.CD-21-1345. Cancer Discov. 2022. PMID: 35176764 Clinical Trial.
AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions.
Guo J, Dai X, Laurent B, Zheng N, Gan W, Zhang J, Guo A, Yuan M, Liu P, Asara JM, Toker A, Shi Y, Pandolfi PP, Wei W. Guo J, et al. Among authors: toker a. Nat Cell Biol. 2019 Feb;21(2):226-237. doi: 10.1038/s41556-018-0261-6. Epub 2019 Jan 28. Nat Cell Biol. 2019. PMID: 30692625 Free PMC article.
Sequence analysis of mutations and translocations across breast cancer subtypes.
Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, Cortes ML, Fernandez-Lopez JC, Peng S, Ardlie KG, Auclair D, Bautista-Piña V, Duke F, Francis J, Jung J, Maffuz-Aziz A, Onofrio RC, Parkin M, Pho NH, Quintanar-Jurado V, Ramos AH, Rebollar-Vega R, Rodriguez-Cuevas S, Romero-Cordoba SL, Schumacher SE, Stransky N, Thompson KM, Uribe-Figueroa L, Baselga J, Beroukhim R, Polyak K, Sgroi DC, Richardson AL, Jimenez-Sanchez G, Lander ES, Gabriel SB, Garraway LA, Golub TR, Melendez-Zajgla J, Toker A, Getz G, Hidalgo-Miranda A, Meyerson M. Banerji S, et al. Among authors: toker a. Nature. 2012 Jun 20;486(7403):405-9. doi: 10.1038/nature11154. Nature. 2012. PMID: 22722202 Free PMC article.
Commentary: Burning Your Bridges.
Hayanga JWA, Dhamija A, Hayanga HK, Fugett J, Toker A. Hayanga JWA, et al. Among authors: toker a. Semin Thorac Cardiovasc Surg. 2020 Winter;32(4):786-787. doi: 10.1053/j.semtcvs.2020.06.009. Epub 2020 Jun 20. Semin Thorac Cardiovasc Surg. 2020. PMID: 32569650 Free PMC article. No abstract available.
401 results